DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q4 2019 13F-HR Holdings
Net value change ($000)
—
New positions
68
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AHCO | 188,855 | — |
| Horizon Therapeutics Public Ltd Co | 171,672 | — |
| Mylan II B.V. | 163,850 | — |
| Orchard Therapeutics plc | 121,856 | — |
| QTTB | 108,585 | — |
| RYTM | 98,482 | — |
| MIRM | 84,567 | — |
| TNDM | 81,150 | — |
| XLRN | 72,618 | — |
| Ra Pharmaceuticals, Inc. | 71,320 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,509
(0.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|